Giuseppe Costante Department : Internal medicine , Endocrinology giuseppe.costante [at] hubruxelles.be Publications Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy. Authors : Jungels C, Pita JM, Costante G Year : 2023 Journal : Curr Opin Oncol Multikinase inhibitors for the treatment of radioiodine refractory thyroid cancer: what have we learned from the 'real-world' experience? Authors : Costante G Year : 2021 Journal : Curr Opin Oncol Calcitonin as a biomarker of C cell disease: recent achievements and current challenges. Authors : Costante G, Meringolo D Year : 2020 Journal : Endocrine Novel therapeutic options for radioiodine-refractory thyroid cancer: redifferentiation and beyond. Authors : Bulotta S, Celano M, Costante G, Russo D Year : 2020 Journal : Curr Opin Oncol Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis. Authors : Meringolo D, Campi I, Costante G Year : 2018 Journal : Endocrine More publications »